Patients diagnosed with bipolar disorder I or II (DSM-5 criteria);
Aged between ≥ 18 and ≤ 65;
Absence of major mood episode for at least 3 months before inclusion (MADRS scores \< 12; YMRS score \< 10);
Presence of residual depressive symptoms, as assessed by the MADRS (score \> 5);
Stabilized dose of mood stabilizer medication for at least 3 months before inclusion.
Written consent
Affiliation to a social security system
Effective contraception for women of childbearing age
You may not be if
Severe physical disorders that may be life-threatening;
Major psychiatric (Axis 1) comorbidities except for anxiety disorders;
Any current substance abuse except for tobacco or cannabis. Substance abuse will be defined by the DSM V criteria;
Somatic disorder that may affect cognitive abilities and brain structures (e.g., HIV infection, MS, lupus, Parkinson's disease, epilepsy, dementia...);
Ongoing non-pharmacological treatment: structured psychotherapeutic interventions (Cognitive Behavioral Therapy - CBT, Interpersonal and Social Rhythm Therapy - IPSRT) as well as brain stimulation techniques (Electroconvulsive Therapy - ECT, Transcranial Magnetic Stimulation - TMS, Deep Brain Stimulation - DBS);
Subject included in clinical and / or therapeutic experimentation in progress.
Patients under legal protection
Prisoners
Pregnancy
Breastfeeding
Clareo Health | Neurofeedback for Bipolar Disorder
